Evidence map›Paper›PMID 42428098›Full record

ArticlemedRxiv : the preprint server for health sciences2026

RESCUE: An end-to-end multi-agent LLM system for proactive rare-disease patient screening in the EHR.

Cong Liu, Alexa Geltzeiler, Adam Afyouni, Mengshu Nie, Kamalakkannan Ravi, Courtney French, Monica Wojcik, Wendy K Chung

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cong LiuBoston Children's Hospital, Department of Pediatrics, Division of Genetics and Genomics, Boston, MA.
Alexa GeltzeilerBoston Children's Hospital, Department of Pediatrics, Division of Genetics and Genomics, Boston, MA.
Adam AfyouniBoston Children's Hospital, Department of Pediatrics, Division of Genetics and Genomics, Boston, MA.
Mengshu NieBoston Children's Hospital, Department of Pediatrics, Division of Genetics and Genomics, Boston, MA.
Kamalakkannan RaviBoston Children's Hospital, Department of Pediatrics, Division of Genetics and Genomics, Boston, MA.
Courtney FrenchBoston Children's Hospital, Information Services Department, Research Computing Group.
Monica WojcikBoston Children's Hospital, Department of Pediatrics, Division of Newborn Medicine & Genetics and Genomics.ORCID 0000-0002-8162-5031
Wendy K ChungBoston Children's Hospital, Department of Pediatrics, Division of Genetics and Genomics, Boston, MA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rare diseases affect a significant portion of the global population, yet patients often endure a lengthy diagnostic odyssey, frequently missing the opportunity for timely diagnoses with exome or genome sequencing (ES/GS). Existing informatics tools often rely on pre-identified patients or rigid, institution-specific rule sets, failing to address the broader operational question of clinical utility and feasibility. Methods: We introduce RESCUE ( Results: Using electronic medical record data from a pediatric hospital, our retrospective evaluation on a holdout set (n=12,591) demonstrates strong discrimination between patients who received diagnostic genomic testing and those who did not (AUC 0.808). Of nearly 500,000 patients in the institutional base, 175,842 met inclusion criteria for screening; among these, RESCUE-flagged candidates were 7.4-fold more likely to receive subsequent genomic assessments compared to controls. Blinded manual chart reviews confirmed that RESCUE identifies previously missed, medically appropriate patients for ES/GS with 80% precision, while simultaneously accounting for prior testing history. Conclusions: By decoupling expert roles into modular agents, RESCUE offers a flexible, scalable, and adaptable framework for screening patients for rare-disease diagnostic genomic testing. This approach overcomes the limitations of traditional rule-based methods and provides a reproducible, agentic pathway to reduce diagnostic delays and improve patient care at an institutional scale.

Identifiers

PMID42428098
PMCPMC13345393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.